Exporter Of Medical Cannabis To Israel

MOCA: Supplying GMP-Certified Medical Cannabis to Israel

Medicinal Organic Cannabis Australia (MOCA) Pty Ltd is a trusted supplier of high-quality, GMP-certified medical cannabis to international markets, including Israel. With a well-established import and distribution network, Israel is one of the largest global consumers of medical cannabis flower. MOCA is committed to providing pharmaceutical-grade cannabis products that meet stringent regulatory requirements, ensuring consistency, safety, and efficacy for patients and healthcare providers.

MOCA’s Commitment to Quality and Compliance

MOCA operates under the strict guidelines set by the Australian Office of Drug Control (ODC), adhering to Good Manufacturing Practice (GMP) standards to ensure the highest quality in all our products. Our company holds the necessary licences to export Australian-grown medical cannabis in both raw and finished product formats, offering flexibility to meet the specific needs of international markets.

All MOCA products are cultivated, processed, and manufactured in accordance with rigorous quality assurance protocols. We work closely with accredited Australian producers and testing facilities to ensure our medical cannabis meets the pharmaceutical standards required by the Israeli Ministry of Health.

Medical Cannabis in Israel

Israel has a well-established medical cannabis program, with a regulated framework for patient access and pharmaceutical distribution. In 2023, the Israeli medical cannabis market was valued at approximately 315 million euros, reflecting the increasing demand for high-quality medicinal cannabis products. The country’s progressive stance on medical cannabis research and clinical applications has made it a leading global importer, with a growing need for reliable and compliant suppliers.

MOCA supports this expanding market by offering premium-grade cannabis products that align with Israel’s regulatory and medical requirements. Our commitment to quality, transparency, and compliance ensures that we provide healthcare professionals and patients with safe and effective treatment options.

Our Product Offering

MOCA supplies a range of GMP-certified medical cannabis products, including:

• Whole Flower: Premium, Australian-grown medical cannabis with standardised cannabinoid profiles.

• Extracts and Oils: Pharmaceutical-grade cannabis extracts formulated for specific therapeutic applications.

• Custom Formulations: Tailored solutions for medical practitioners and pharmaceutical distributors.

Each product is subject to strict quality control testing, ensuring batch-to-batch consistency, purity, and potency. Our cannabis is cultivated in controlled environments using advanced cultivation techniques to maintain optimal therapeutic efficacy.

Regulatory Compliance and Export Capabilities

MOCA’s operations are fully licensed by the Australian Office of Drug Control, allowing us to export medical cannabis to international markets, including Israel. We ensure compliance with all relevant regulations, including:

• TGA (Therapeutic Goods Administration) Standards: All MOCA products comply with Australian regulatory requirements for medical cannabis.

• GMP Certification: Our manufacturing and processing facilities adhere to Good Manufacturing Practice standards, ensuring pharmaceutical-grade quality.

• Israeli Ministry of Health Regulations: We work closely with our partners to ensure seamless importation and compliance with Israel’s strict pharmaceutical and medical cannabis regulations.

Our experience in international logistics and regulatory compliance allows us to provide a streamlined supply chain solution, ensuring timely and secure delivery of medical cannabis products to Israel.

Partnering with MOCA

MOCA collaborates with pharmaceutical companies, medical professionals, and distributors in Israel to support patient access to high-quality medical cannabis. Our team of experts offers:

• Reliable Supply Chain Solutions: Ensuring consistent availability of pharmaceutical-grade cannabis.

• Regulatory Expertise: Navigating international compliance requirements for seamless importation.

• Customised Product Solutions: Tailoring formulations to meet the specific needs of healthcare providers and patients.

We are committed to advancing patient care through high-quality medical cannabis, backed by scientific research and regulatory compliance.